PROCEEDINGS VOLUME 1065
OE/LASE '89 | 15-20 JANUARY 1989
Photodynamic Therapy: Mechanisms
IN THIS VOLUME

0 Sessions, 24 Papers, 0 Presentations
All Papers  (24)
OE/LASE '89
15-20 January 1989
Los Angeles, CA, United States
All Papers
Proc. SPIE 1065, Possible Implications Of Vascular Damage For Tumor Cell Inactivation In Vivo: Comparison Of Different Photosensitizers, 0000 (13 June 1989); doi: 10.1117/12.977998
Proc. SPIE 1065, Microvascular Effects Of Photodynamic Therapy, 0000 (13 June 1989); doi: 10.1117/12.952016
Proc. SPIE 1065, Role mediators of inflammation and cells in porphyrin-induced phototoxicity, 0000 (13 June 1989); doi: 10.1117/12.978000
Proc. SPIE 1065, Blood Flow Changes In Transplantable Urothelial Tumors Treated With The Metallopurpurin, SnET2 And Light., 0000 (13 June 1989); doi: 10.1117/12.978001
Proc. SPIE 1065, Modifications In Intratumor Microenvironment With PDT, 0000 (13 June 1989); doi: 10.1117/12.978002
Proc. SPIE 1065, Lethality In Mice Following Localized Photodynamic Therapy, 0000 (13 June 1989); doi: 10.1117/12.978003
Proc. SPIE 1065, Immunologic Effects Of Peritoneal Photodynamic Treatment, 0000 (13 June 1989); doi: 10.1117/12.978004
Proc. SPIE 1065, Immune Response Following Photodynamic Therapy For Bladder Cancer, 0000 (13 June 1989); doi: 10.1117/12.978005
Proc. SPIE 1065, The Preparation And Application Of Porphyrin-Monoclonal Antibodies For Cancer Therapy, 0000 (13 June 1989); doi: 10.1117/12.978006
Proc. SPIE 1065, Immunologic Targeting Of Cancer Cells, 0000 (13 June 1989); doi: 10.1117/12.978007
Proc. SPIE 1065, PDT Dosimetry And Response, 0000 (13 June 1989); doi: 10.1117/12.978008
Proc. SPIE 1065, Simple Theory, Measurements, And Rules Of Thumb For Dosimetry During Photodynamic Therapy., 0000 (13 June 1989); doi: 10.1117/12.978009
Proc. SPIE 1065, In Vivo Light Dosimetry For Interstitial Photodynamic Therapy: Results Of Clinical Importance., 0000 (13 June 1989); doi: 10.1117/12.978010
Proc. SPIE 1065, Quantitative Reflectance Spectrophotometry For The Noninvasive Measurement Of Photosensitizer Concentration In Tissue During Photodynamic Therapy, 0000 (13 June 1989); doi: 10.1117/12.978011
Proc. SPIE 1065, Measurements Of Singlet Oxygen In Photodynamic Therapy, 0000 (13 June 1989); doi: 10.1117/12.978012
Proc. SPIE 1065, Preclinical Evaluation Of Photosensitizing Agents, 0000 (13 June 1989); doi: 10.1117/12.978013
Proc. SPIE 1065, Tumor Uptake And Photodynamic Activity Of Sulfonated Metallo Phthalocyanines, 0000 (13 June 1989); doi: 10.1117/12.978014
Proc. SPIE 1065, Photodynamic Action Of Benzochlorins, 0000 (13 June 1989); doi: 10.1117/12.978015
Proc. SPIE 1065, Differential Uptake Of Benzoporphyrin Derivative (BPD) By Leukemic Versus Normal Cells, 0000 (13 June 1989); doi: 10.1117/12.978016
Proc. SPIE 1065, Chemistry Of Photofrin II And Some New Photosensitizers, 0000 (13 June 1989); doi: 10.1117/12.978017
Proc. SPIE 1065, Cell Biology And Photochemistry Of Photodynamic Sensitizers, 0000 (13 June 1989); doi: 10.1117/12.978018
Proc. SPIE 1065, Tissue Distribution Of Chloroaluminium Sulfonated Phthalocyanine In Dogs, 0000 (13 June 1989); doi: 10.1117/12.978019
Proc. SPIE 1065, Photosensitizing Efficiencies Of Poryphyrins, Chlorins, And Phthalocyanines, 0000 (13 June 1989); doi: 10.1117/12.978020
Proc. SPIE 1065, Intracellular Distribution Of Porphyrin-Based Photosensitizers In In Vitro Cultured Human Bladder Tumor Cells., 0000 (13 June 1989); doi: 10.1117/12.978021
Back to Top